应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
STOK Stoke Therapeutics, Inc.
休市中 05-17 16:00:00 EDT
13.90
-0.13
-0.93%
盘后
13.90
+0.00
0.00%
16:36 EDT
最高
14.18
最低
13.73
成交量
47.11万
今开
14.11
昨收
14.03
日振幅
3.17%
总市值
7.24亿
流通市值
5.56亿
总股本
5,212万
成交额
656.67万
换手率
1.18%
流通股本
3,998万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
加拿大投资银行集团:维持Stoke Therapeutics(STOK.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。
智通财经 · 05-07
加拿大投资银行集团:维持Stoke Therapeutics(STOK.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。
Stoke Therapeutics Inc 预计每股亏损61美分 - 财报前瞻
Reuters · 05-01
Stoke Therapeutics Inc 预计每股亏损61美分 - 财报前瞻
Stoke Therapeutics, Inc.盘中异动 急速下挫5.51%
自选股智能写手 · 04-02
Stoke Therapeutics, Inc.盘中异动 急速下挫5.51%
Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨6.55%报6.18美元
自选股智能写手 · 03-21
Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨6.55%报6.18美元
暂无数据
公司概况
公司名称:
Stoke Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Stoke Therapeutics, Inc.成立于2014年6月,根据特拉华州法律注册成立。该公司是一家早期生物制药公司,通过精确上调蛋白质表达,开创了治疗严重遗传疾病根本原因的新方法。他们正在开发新的反义寡核苷酸,或ASO,针对核糖核酸或RNA,调节前体的药物-作用RNA或前mRNA,剪接以在需要时上调蛋白质表达并且具有接近正常水平的适当特异性。他们利用其专有技术平台,核基因输出的靶向增强或TANGO,设计ASO以通过患者中的个体基因上调蛋白质的表达。他们的方法旨在以高度精确,持久和受控的方式向广泛的相关组织(包括中枢神经系统或中枢神经系统,眼睛,肾脏和肝脏)提供疾病改善疗法。
发行价格:
--
{"stockData":{"symbol":"STOK","market":"US","secType":"STK","nameCN":"Stoke Therapeutics, Inc.","latestPrice":13.9,"timestamp":1715976000000,"preClose":14.03,"halted":0,"volume":471125,"hourTrading":{"tag":"盘后","latestPrice":13.9,"preClose":13.9,"latestTime":"16:36 EDT","volume":5124,"amount":71213.42,"timestamp":1715978184475},"delay":0,"floatShares":39976417,"shares":52119860,"eps":-2.415895,"marketStatus":"休市中","marketStatusCode":7,"change":-0.13,"latestTime":"05-17 16:00:00 EDT","open":14.11,"high":14.175,"low":13.73,"amount":6566716.45075,"amplitude":0.031718,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.415895,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1560916800000,"adjPreClose":14.03,"preHourTrading":{"tag":"盘前","latestPrice":14,"preClose":14.03,"latestTime":"09:15 EDT","volume":10,"amount":140,"timestamp":1715951721232},"postHourTrading":{"tag":"盘后","latestPrice":13.9,"preClose":13.9,"latestTime":"16:36 EDT","volume":5124,"amount":71213.42,"timestamp":1715978184475},"volumeRatio":0.5633135301584234},"requestUrl":"/m/hq/s/STOK/tweets","defaultTab":"tweets","newsList":[{"id":"2433786337","title":"加拿大投资银行集团:维持Stoke Therapeutics(STOK.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786337","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433786337?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:25","pubTimestamp":1715091952,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Stoke Therapeutics(STOK.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432377875","title":"Stoke Therapeutics Inc 预计每股亏损61美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432377875","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432377875?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:17","pubTimestamp":1714493843,"startTime":"0","endTime":"0","summary":" * Stoke Therapeutics Inc 预计将在5月2日公布截至2024年3月31日的业绩(估计),季度收入将出现下降。* 根据LSEG的数据,7位分析师的平均预期显示,这家总部位于马萨诸塞州贝德福德的公司的营收预计将从去年同期的515万美元下降37.6%,至321.4万美元。* LSEG 分析师对 Stoke Therapeutics Inc 的平均预期是每股亏损 61 美分。* 华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元,高于其最新收盘价 11.86 美元。4月30日 - 以往季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424093045","title":"Stoke Therapeutics, Inc.盘中异动 急速下挫5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424093045","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424093045?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:31","pubTimestamp":1712064665,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时31分,Stoke Therapeutics, Inc.股票出现异动,股价急速下跌5.51%。Stoke Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.14%。Stoke Therapeutics, Inc.公司简介:Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。消息层面,截至21时31分,《Form 144 | Stoke Therapeutics高管拟出售9,426股股份,价值约12.73万美元》资讯为影响Stoke Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131067a50b5a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131067a50b5a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421332774","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨6.55%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421332774","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421332774?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:16","pubTimestamp":1710958600,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时16分,Stoke Therapeutics, Inc.股票出现波动,股价大幅上涨6.55%。Stoke Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Xtl生物制药、Surrozen Inc C/Wts 01/08/2031 、Eiger Biopharmaceuticals, Inc.涨幅较大,Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm Plc较为活跃,换手率分别为206.93%、86.05%、46.19%,振幅较大的相关个股有Xtl生物制药、Nls Pharmaceutics Ltd.、Igc Pharma, Inc.,振幅分别为157.69%、66.78%、43.55%。Stoke Therapeutics, Inc.公司简介:Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210216407a4dfec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210216407a4dfec3&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.stoketherapeutics.com","stockEarnings":[{"period":"1week","weight":0.2108},{"period":"1month","weight":0.186},{"period":"3month","weight":1.6376},{"period":"6month","weight":2.2938},{"period":"1year","weight":0.25},{"period":"ytd","weight":1.6426}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Stoke Therapeutics, Inc.成立于2014年6月,根据特拉华州法律注册成立。该公司是一家早期生物制药公司,通过精确上调蛋白质表达,开创了治疗严重遗传疾病根本原因的新方法。他们正在开发新的反义寡核苷酸,或ASO,针对核糖核酸或RNA,调节前体的药物-作用RNA或前mRNA,剪接以在需要时上调蛋白质表达并且具有接近正常水平的适当特异性。他们利用其专有技术平台,核基因输出的靶向增强或TANGO,设计ASO以通过患者中的个体基因上调蛋白质的表达。他们的方法旨在以高度精确,持久和受控的方式向广泛的相关组织(包括中枢神经系统或中枢神经系统,眼睛,肾脏和肝脏)提供疾病改善疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.047456},{"month":2,"riseRate":0.4,"avgChangeRate":0.077295},{"month":3,"riseRate":0.4,"avgChangeRate":0.066891},{"month":4,"riseRate":0.2,"avgChangeRate":-0.135958},{"month":5,"riseRate":0.8,"avgChangeRate":0.180362},{"month":6,"riseRate":0.25,"avgChangeRate":-0.062453},{"month":7,"riseRate":0.4,"avgChangeRate":-0.100682},{"month":8,"riseRate":0.6,"avgChangeRate":0.092897},{"month":9,"riseRate":0.2,"avgChangeRate":-0.152069},{"month":10,"riseRate":0.6,"avgChangeRate":0.097204},{"month":11,"riseRate":0.4,"avgChangeRate":-0.037094},{"month":12,"riseRate":0.8,"avgChangeRate":0.184055}],"exchange":"NASDAQ","name":"Stoke Therapeutics, Inc.","nameEN":"Stoke Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Stoke Therapeutics, Inc.,STOK,Stoke Therapeutics, Inc.股票,Stoke Therapeutics, Inc.股票老虎,Stoke Therapeutics, Inc.股票老虎国际,Stoke Therapeutics, Inc.行情,Stoke Therapeutics, Inc.股票行情,Stoke Therapeutics, Inc.股价,Stoke Therapeutics, Inc.股市,Stoke Therapeutics, Inc.股票价格,Stoke Therapeutics, Inc.股票交易,Stoke Therapeutics, Inc.股票购买,Stoke Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}